← Back
Data updated: Mar 10, 2026
RITEDOSE CORP
Respiratory
RITEDOSE CORP is a generic drug manufacturer focused on Respiratory.
2001
Since
6
Drugs
-
Trials
26
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
IPRATROPIUM BROMIDE 2026-02-23
ALBUTEROL SULFATE 2025-12-01
ALBUTEROL SULFATE 2025-11-21
Labeling
ARFORMOTEROL TARTRATE 2025-04-25
ALBUTEROL SULFATE 2025-03-12
ARFORMOTEROL TARTRATE 2025-03-07
ALBUTEROL SULFATE AND IPRATROPIUM BROMIDE 2025-02-24
Labeling
FORMOTEROL FUMARATE 2025-02-11
IPRATROPIUM BROMIDE 2025-02-07
ARFORMOTEROL TARTRATE 2025-02-03
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Respiratory 100%
2 drugs
Pipeline Strength Pro
Loading...
Discontinued (2)
Company Info
- First Approval
- 2001-01-26
- Latest
- 2025-03-12
- Applications
- 8